N-[(1R)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332048415 (In-Stock Building Blocks)
- IUPAC Name
- N-[(1R)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide
- Mol formula
- C12H13N3O3S
- Mol weight
- 279 Da
- Catalog Number(s)
- BBLS21332048415, EN300-54646007, bbls21332048415
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.18
- Heavy atoms count
- 19
- Rotatable bond count
- 4
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.166
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(1R)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide (C12H13N3O3S) - CSSB21332048415](/st/structure/200/63c573793ae84bd94dec502ed1eaf6fd/C%255BC%2540%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png "C12H13N3O3S")
- Zoom the structure
- CSSB21332048415
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 575.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 603.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 630.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 657.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 685.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,343.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,987.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,945.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[(1S)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB21332097262](/st/structure/200/58e976d7c50b8004cb0f2927910164d3/C%255BC%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-{1-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332124882](/st/structure/200/c5089eb1ece95336016f5aa56aac7384/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DC%2528F%2529C%253DC1.png)
![Chemical structure of N-{1-[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332117392](/st/structure/200/b8dc2376bfd666bc9b1e7783fb2794d7/COC1%253DCC%253DCC%2528%253DC1%2529C1%253DNOC%2528%253DN1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-{1-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332116552](/st/structure/200/447a0366856bf4896216748a0cde3a74/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
![Chemical structure of N-{1-[3-(4-ethylphenyl)-1,2,4-oxadiazol-5-yl]ethyl}ethene-1-sulfonamide - CSSB21332126595](/st/structure/200/a61b5539c20038ebb44e655e20554740/CCC1%253DCC%253DC%2528C%253DC1%2529C1%253DNOC%2528%253DN1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]ethene-1-sulfonamide - CSSB21332167021](/st/structure/200/206a1004fdd927941b381524f9bfd415/CC%2528CC1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]ethene-1-sulfonamide - CSSB21332124556](/st/structure/200/4bac37bb44ecfe626493c1a0954ed204/CC%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC%2528%253DNO1%2529C1%253DCC%253DCC%253DC1.png)
